Biobanks Market Size, Share & Trends Analysis Report By Product (LIMS, Biobanking Equipment), Biospecimen Type (Organs, Stem Cells), Biobank Type (Real, Virtual), Service, Application, Segment Forecasts, 2024 - 2030
- Report ID: GVR-2-68038-564-9
- Number of Pages: 185
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Biospecimen Type Outlook (Revenue in USD Million; 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Biobanks Type Outlook (Revenue in USD Million; 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Application Outlook (Revenue in USD Million; 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- North America Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- North America Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- North America Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- North America Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- North America Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- North America End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- U.S.
- U.S. Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- U.S. Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- U.S. Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- U.S. Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- U.S. Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- U.S. Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- U.S. End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- U.S. Product Outlook (Revenue in USD Million, 2018 - 2030)
- Canada
- Canada Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Canada Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Canada Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Canada Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Canada Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Canada Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Canada End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Canada Product Outlook (Revenue in USD Million, 2018 - 2030)
- North America Product Outlook (Revenue in USD Million, 2018 - 2030)
- Europe
- Europe Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Europe Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Europe Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Europe Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Europe Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Europe Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Europe America End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Germany
- Germany Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Germany Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Germany Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Germany Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Germany Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- GERMANY Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- GERMANY End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Germany Product Outlook (Revenue in USD Million, 2018 - 2030)
- UK
- UK Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- UK Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- UK Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- UK Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- UK Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- UK Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- UK End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- UK Product Outlook (Revenue in USD Million, 2018 - 2030)
- France
- France Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- France Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- France Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- France Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- France Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- France Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- France End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- France Product Outlook (Revenue in USD Million, 2018 - 2030)
- Italy
- Italy Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Italy Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Italy Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Italy Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Italy Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Italy Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Italy End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Italy Product Outlook (Revenue in USD Million, 2018 - 2030)
- Spain
- Spain Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Spain Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Spain Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Spain Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Spain Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Spain Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Spain End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Spain Product Outlook (Revenue in USD Million, 2018 - 2030)
- Denmark
- Denmark Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Denmark Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Denmark Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Denmark Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Denmark Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Denmark Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Denmark End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Denmark Product Outlook (Revenue in USD Million, 2018 - 2030)
- Sweden
- Sweden Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Sweden Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Sweden Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Sweden Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Sweden Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Sweden Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Sweden End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Sweden Product Outlook (Revenue in USD Million, 2018 - 2030)
- Norway
- Norway Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Norway Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Norway Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Norway Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Norway Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Norway Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Norway End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Norway Product Outlook (Revenue in USD Million, 2018 - 2030)
- Europe Product Outlook (Revenue in USD Million, 2018 - 2030)
- Asia Pacific
- Asia Pacific Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Asia Pacific Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Asia Pacific Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Asia Pacific Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Asia Pacific Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Asia Pacific Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Asia Pacific End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- China
- China Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- China Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- China Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- China Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- China Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- China Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- China End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- China Product Outlook (Revenue in USD Million, 2018 - 2030)
- Japan
- Japan Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Japan Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Japan Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Japan Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Japan Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Japan Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Japan End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Japan Product Outlook (Revenue in USD Million, 2018 - 2030)
- India
- India Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- India Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- India Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- India Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- India Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- India Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- India End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- India Product Outlook (Revenue in USD Million, 2018 - 2030)
- Thailand
- Thailand Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Thailand Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Thailand Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Thailand Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Thailand Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Thailand Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Thailand End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Thailand Product Outlook (Revenue in USD Million, 2018 - 2030)
- South Korea
- South Korea Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- South Korea Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- South Korea Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- South Korea Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- South Korea Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- South Korea Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- South Korea End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- South Korea Product Outlook (Revenue in USD Million, 2018 - 2030)
- Australia
- Australia Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Australia Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Australia Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Australia Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Australia Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Australia Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Australia End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Australia Product Outlook (Revenue in USD Million, 2018 - 2030)
- Asia Pacific Product Outlook (Revenue in USD Million, 2018 - 2030)
- Latin America
- Latin America Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Latin America Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Latin America Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Latin America Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Latin America Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- LATAM Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- LATAM End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Brazil
- Brazil Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Brazil Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Brazil Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Brazil Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Brazil Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Brazil Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Brazil End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Brazil Product Outlook (Revenue in USD Million, 2018 - 2030)
- Mexico
- Mexico Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Mexico Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Mexico Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Mexico Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Mexico Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Mexico Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Mexico End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Mexico Product Outlook (Revenue in USD Million, 2018 - 2030)
- Argentina
- Argentina Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Argentina Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Argentina Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Argentina Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Argentina Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Argentina Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Argentina End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Argentina Product Outlook (Revenue in USD Million, 2018 - 2030)
- Latin America Product Outlook (Revenue in USD Million, 2018 - 2030)
- Middle East and Africa
- Middle East and Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Middle East and Africa Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Middle East and Africa Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Middle East and Africa Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Middle East and Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- MEA Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- MEA End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- South Africa
- South Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- South Africa Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- South Africa Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- South Africa Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- South Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- South Africa Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- South Africa End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- South Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
- Saudi Arabia
- Saudi Arabia Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Saudi Arabia Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Saudi Arabia Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Saudi Arabia Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Saudi Arabia Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Saudi Arbia Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Saudi Arabia End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Saudi Arabia Product Outlook (Revenue in USD Million, 2018 - 2030)
- UAE
- UAE Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- UAE Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- UAE Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- UAE Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- UAE Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- UAE Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- UAE End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- UAE Product Outlook (Revenue in USD Million, 2018 - 2030)
- Kuwait
- Kuwait Product Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Kuwait Service Outlook (Revenue in USD Million, 2018 - 2030)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Kuwait Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Kuwait Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Kuwait Application Outlook (Revenue in USD Million, 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Kuwait Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
- University Owned
- National/Regional Agencies Owned
- Non-profit Organizations Owned
- Private Organization Owned
- Kuwait End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- CROs & CMOs
- Academic & Research Institutes
- Hospitals
- Kuwait Product Outlook (Revenue in USD Million, 2018 - 2030)
- Middle East and Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
- North America
Biobanks Market Dynamics
Driver: Role of technology in managing biobanks
Technological advances, especially process automation & computerization, have revolutionized the management of biobanks. Automation is vital in biobanking, where processing, storage, and distribution of samples are involved. Furthermore, the focus on population-based research & precision medicine has increased in North America, Europe, and Asia due to the prevalence of chronic diseases and large geriatric population. These studies involve millions of participants, which leads to large sample collection drives at multiple collection centres with associated clinical & sequence datasets. Large collections are being managed by liquid handling workstations & automated sample storage systems because they reduce the amount of time required to process, store, and distribute samples. The coupling of computerized databases & biobanks with robotics accelerates specimen processing & sampling, which in turn maintains the annotations & locations of specimens. Several software firms are developing packages to support biobanks for applications, such as expenses, consent documentation, tracking inventory, and clinical & laboratory data handling. This continuous digitization & developments in technology will boost the market growth.
Driver: Rising number of clinical trials
The number of clinical trials conducted by companies & research institutes worldwide has increased by threefold since 2010. As of 2021, there were 420,920 clinical studies listed in a database by the U.S. National Library of Medicine. Biobanks globally are storing millions of samples that can be used extensively for clinical & biomedical research. One of the biggest challenges pharmaceutical companies are facing is the rising cost of clinical trials. Biobanks offer biomedical samples that can be used in safety & efficacy studies. Samples of various patients based on demographics can be obtained from biobanks and researched by pharmaceutical companies & research institutes. Biobanks not only provide wide variety of biomedical samples to companies conducting clinical trials but also help reduce the costs associated with clinical trials. This shift to specimen-driven clinical testing is expected to drive the biobank industry.
Restraint: Sustainability challenges
Sustainability concerns are major issues for biobanks globally. Biobanks need well-established processes and are required to be economically stable to continuously provide samples and stay up to date with rapid advances in technology. Moreover, ethical & legal compliance is required for sustained biobanking operations, along with compliance with various changing standardizations & specifications like ISO and CEN/TS for serving a worldwide consumer base. Storage conditions also pose threat to the integrity of the specimens. Conditions like storage temperature, intended duration, the frequency of biospecimen use, purpose, and recovery rate are crucial for biobanking.
What Does This Report Include?
This section will provide insights into the contents included in this biobanks market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Biobanks market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Biobanks market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
